InflaRx NV (IFRX)
1.475
0.00 (0.00%)
USD |
NASDAQ |
Oct 15, 12:57
InflaRx Total Long Term Debt (Quarterly) : 0.9526M for June 30, 2026
Total Long Term Debt (Quarterly) Chart
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.9526M |
| March 31, 2026 | 0.9483M |
| September 30, 2025 | 1.141M |
| June 30, 2025 | 0.7032M |
| March 31, 2025 | 0.7589M |
| September 30, 2024 | 1.002M |
| June 30, 2024 | 1.070M |
| March 31, 2024 | 1.194M |
| December 31, 2023 | 1.237M |
| September 30, 2023 | 1.192M |
| June 30, 2023 | 1.277M |
| March 31, 2023 | 1.371M |
| December 31, 2022 | 1.448M |
| September 30, 2022 | 1.425M |
| June 30, 2022 | 1.610M |
| March 31, 2022 | 1.495M |
| December 31, 2021 | 1.629M |
| September 30, 2021 | 1.761M |
| June 30, 2021 | 1.903M |
| March 31, 2021 | 0.5507M |
| Date | Value |
|---|---|
| December 31, 2020 | 0.684M |
| September 30, 2020 | 0.7443M |
| June 30, 2020 | 0.8173M |
| March 31, 2020 | 0.8327M |
| December 31, 2019 | 0.9496M |
| September 30, 2019 | 0.9864M |
| June 30, 2019 | 1.123M |
| March 31, 2019 | 0.7613M |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 67.89M |
| June 30, 2017 | 64.54M |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
Total Long Term Debt Definition
Represents a company's total debt maturing for more than 12 months of the reporting period.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Long Term Debt (Quarterly) Benchmarks
| MediGene AG | -- |
| BioNTech SE | 349.05M |
| Immatics NV | 16.70M |
| Arrowhead Pharmaceuticals, Inc. | 1.371B |
| Oncolytics Biotech, Inc. | 0.31M |